Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$25.39 - $32.61 $3.7 Million - $4.76 Million
-145,900 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$19.92 - $31.6 $267,844 - $424,893
-13,446 Reduced 8.44%
145,900 $4.44 Million
Q4 2020

Feb 02, 2021

SELL
$12.16 - $19.77 $36,480 - $59,310
-3,000 Reduced 1.85%
159,346 $3.15 Million
Q3 2020

Nov 05, 2020

BUY
$11.25 - $14.75 $54,000 - $70,800
4,800 Added 3.05%
162,346 $2.12 Million
Q2 2020

Aug 12, 2020

SELL
$10.69 - $16.49 $9,621 - $14,840
-900 Reduced 0.57%
157,546 $1.79 Million
Q1 2020

May 12, 2020

SELL
$9.78 - $29.53 $222,006 - $670,331
-22,700 Reduced 12.53%
158,446 $2.27 Million
Q4 2019

Jan 27, 2020

BUY
$20.93 - $35.1 $221,041 - $370,691
10,561 Added 6.19%
181,146 $4.93 Million
Q3 2019

Oct 31, 2019

BUY
$22.08 - $47.08 $617,577 - $1.32 Million
27,970 Added 19.61%
170,585 $4.88 Million
Q2 2019

Aug 15, 2019

SELL
$22.67 - $35.0 $425,447 - $656,845
-18,767 Reduced 11.63%
142,615 $3.96 Million
Q1 2019

May 03, 2019

SELL
$26.93 - $34.7 $88,922 - $114,579
-3,302 Reduced 2.01%
161,382 $5.36 Million
Q4 2018

Feb 08, 2019

SELL
$27.23 - $45.56 $437,695 - $732,331
-16,074 Reduced 8.89%
164,684 $4.79 Million
Q3 2018

Nov 13, 2018

BUY
$37.57 - $50.34 $533,681 - $715,079
14,205 Added 8.53%
180,758 $8.32 Million
Q2 2018

Aug 15, 2018

SELL
$27.75 - $40.17 $2.92 Million - $4.23 Million
-105,372 Reduced 38.75%
166,553 $6.22 Million
Q1 2018

May 11, 2018

SELL
$28.83 - $41.01 $1.35 Million - $1.91 Million
-46,692 Reduced 14.65%
271,925 $8.04 Million
Q4 2017

Feb 06, 2018

BUY
$28.45 - $37.14 $948,437 - $1.24 Million
33,337 Added 11.69%
318,617 $10.9 Million
Q3 2017

Nov 15, 2017

BUY
$24.01 - $36.2 $6.85 Million - $10.3 Million
285,280
285,280 $10.3 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.01B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.